Bioray Biotech Co., Ltd (7561.TWO)
TWD 19.35
(-1.02%)
TWD 19.35
(-1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -762 Thousand | 2.47 Million | 8.82 Million | 1.67 Million | 62.31 Million |
| Net Income | -14.18 Million | 682 Thousand | -6.17 Million | -1.45 Million | 19.48 Million |
| Depreciation & Amortization | 25 Million | 22.22 Million | 19.08 Million | 15.27 Million | 15.42 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 19 Thousand | - | - | - |
| Change in working capital | -15.01 Million | -21.96 Million | -4.67 Million | -8.7 Million | 20.32 Million |
| Other non-cash items | 1.73 Million | 254 Thousand | 900 Thousand | 1.03 Million | 7.08 Million |
| Investing Cash Flow | -12.54 Million | -59.63 Million | -19.79 Million | -52.89 Million | -91.26 Million |
| Investments in PPE | -10.18 Million | -60.38 Million | -15.53 Million | -51.37 Million | -62.76 Million |
| Acquisitions | -3.53 Million | - | - | - | -54.4 Million |
| Investment purchases | - | - | -4.8 Million | -3.1 Million | - |
| Sales/Maturities of investments | 1 Million | - | - | - | 25.94 Million |
| Other Investing Activities | -30 Thousand | 394 Thousand | -4.81 Million | 1.49 Million | -378 Thousand |
| Financing Cash Flow | -28.73 Million | 69.91 Million | -8.63 Million | -15.32 Million | 565 Thousand |
| Debt repayment | -15 Million | -10 Million | -2.2 Million | -6.07 Million | -7.22 Million |
| Dividends payments | -6.01 Million | - | - | -8.02 Million | -9.75 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 87.04 Million | - | - | - |
| Other Financing Activities | -15.12 Million | -370 Thousand | 471 Thousand | -55 Thousand | -8.53 Million |
| Accounts receivables | -555 Thousand | -5.96 Million | -13.65 Million | 7.87 Million | -11.63 Million |
| Accounts payables | -3.14 Million | - | - | - | - |
| Inventory | -4.12 Million | -6.43 Million | 2.81 Million | -12.62 Million | -414 Thousand |
| Other working capital | -4.66 Million | -7.8 Million | -72 Thousand | -1.19 Million | 32.36 Million |
| Cash at beginning of period | 139.06 Million | 126.31 Million | 145.9 Million | 212.95 Million | 241.73 Million |
| Cash at end of period | 97.02 Million | 139.06 Million | 126.31 Million | 145.9 Million | 212.95 Million |
| Capital Expenditure | -10.18 Million | -60.38 Million | -15.53 Million | -51.37 Million | -62.76 Million |
| Effect of forex changes on cash | 3000.00 | -14 Thousand | 5000.00 | -500 Thousand | -387 Thousand |
| Net cash flow / Change in cash | -42.04 Million | 12.75 Million | -19.59 Million | -67.05 Million | -28.77 Million |
| Free Cash Flow | -10.94 Million | -57.9 Million | -6.7 Million | -49.69 Million | -448 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.13 Million | -5.13 Million | -2.76 Million | -14.18 Million | -2.76 Million | -3.01 Million |
| Depreciation & Amortization | 6.51 Million | 6.51 Million | 6.22 Million | 25 Million | 6.22 Million | 6.01 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.17 Million | -2.17 Million | -1.06 Million | -15.01 Million | -1.06 Million | -3.6 Million |
| Other non-cash items | 756.5 Thousand | 756.5 Thousand | 863 Thousand | 1.73 Million | 863 Thousand | -3.03 Million |
| Investing Cash Flow | 9.81 Million | 9.81 Million | -661.5 Thousand | -12.54 Million | -661.5 Thousand | -5.61 Million |
| Investments in PPE | -658.5 Thousand | -658.5 Thousand | -631.5 Thousand | -10.18 Million | -631.5 Thousand | -4.37 Million |
| Acquisitions | 20.56 Million | - | - | -3.53 Million | - | -1.76 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 1 Million | - | - |
| Other Investing Activities | 10.47 Million | 10.47 Million | -30 Thousand | -30 Thousand | -30 Thousand | 534 Thousand |
| Financing Cash Flow | 11.98 Million | 11.98 Million | -4.84 Million | -28.73 Million | -4.84 Million | -9.52 Million |
| Debt repayment | -35 Million | - | - | -15 Million | - | - |
| Dividends payments | - | - | -3 Million | -6.01 Million | -3 Million | - |
| Common Stock Repurchased | -3.33 Million | -3.33 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.31 Million | 15.31 Million | -1.83 Million | -15.12 Million | -1.83 Million | -9.52 Million |
| Accounts receivables | -406.5 Thousand | -406.5 Thousand | -4.27 Million | -555 Thousand | -4.27 Million | 3.99 Million |
| Accounts payables | 3.24 Million | - | - | - | - | - |
| Inventory | -772 Thousand | -772 Thousand | 4.45 Million | -4.12 Million | 4.45 Million | -6.52 Million |
| Other working capital | -994.5 Thousand | -994.5 Thousand | -1.25 Million | -4.66 Million | -1.25 Million | -1.07 Million |
| Cash at beginning of period | 97.02 Million | - | - | 139.06 Million | - | - |
| Cash at end of period | 21.76 Million | 21.76 Million | -2.25 Million | 97.02 Million | -2.25 Million | -18.76 Million |
| Capital Expenditure | -658.5 Thousand | -658.5 Thousand | -631.5 Thousand | -10.18 Million | -631.5 Thousand | -4.37 Million |
| Effect of forex changes on cash | - | - | 2500.00 | 3000.00 | 2500.00 | -1000.00 |
| Net cash flow / Change in cash | -75.26 Million | 21.76 Million | -2.25 Million | -42.04 Million | -2.25 Million | -18.76 Million |
| Free Cash Flow | -695.5 Thousand | -695.5 Thousand | 2.61 Million | -10.94 Million | 2.61 Million | -8 Million |
GGGSY
ANGH
AJWAFUN
KONMY
PREV
RECY-B